Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidence. R Çiftçiler, IC Haznedaroglu European Review for Medical & Pharmacological Sciences 25 (24), 2021 | 41 | 2021 |
The factors affecting early death in newly diagnosed APL patients R Ciftciler, IC Haznedaroglu, S Aksu, O Ozcebe, N Sayınalp, UY Malkan, ... Open Medicine 14 (1), 647-652, 2019 | 26 | 2019 |
The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B R Ciftciler, S Ozenirler, AA Yucel, M Cengiz, G Erkan, E Buyukdemirci, ... Journal of clinical laboratory analysis 31 (5), e22109, 2017 | 19 | 2017 |
Covid-19 scientific publications from Turkey R Çiftçiler, İC Haznedaroğlu, A Tufan, MA Öztürk Turkish journal of medical sciences 51 (3), 877-889, 2021 | 18 | 2021 |
Pathobiological interactions of local bone marrow renin-angiotensin system and central nervous system in systemic arterial hypertension R Ciftciler, IC Haznedaroglu Frontiers in Endocrinology 11, 544262, 2020 | 16 | 2020 |
Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia H Erdal, R Ciftciler, SC Tuncer, O Özcan Journal of Investigative Medicine 71 (1), 62-66, 2023 | 14 | 2023 |
Predictive factors for stem cell mobilization failure in multiple myeloma patients: a single center experience H Goker, R Ciftciler, H Demiroglu, M Turgut, N Sayınalp, IC Haznedaroglu, ... Transfusion and Apheresis Science 59 (1), 102595, 2020 | 14 | 2020 |
Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation R Ciftciler, H Goker, Y Buyukasık, T Karaagac, S Aksu, F Tekin, ... Transfusion and Apheresis Science 59 (1), 102597, 2020 | 12 | 2020 |
Ankaferd hemostat: from molecules to medicine R Ciftciler, IC Haznedaroğlu Turkish journal of medical sciences 50 (10), 1739-1750, 2020 | 11 | 2020 |
Evaluation of the survival outcomes of multiple myeloma patients according to their plasmacytoma presentation at diagnosis R Ciftciler, H Göker, H Demiroğlu, S Aksu, N SAYINALP, ... Turkish Journal of Hematology 37 (4), 2020 | 11 | 2020 |
Local bone marrow renin-angiotensin system and COVID-19 R Ciftciler, A Ciftciler, İ HAZNEDAROĞLU UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI 30 (2), 2020 | 10 | 2020 |
The importance of microbiota in hematology R Ciftciler, AE Ciftciler Transfusion and Apheresis Science 61 (2), 103320, 2022 | 9 | 2022 |
The impact of early versus late platelet and neutrophil recovery after induction chemotherapy on survival outcomes of patients with acute myeloid leukemia R Çiftçiler, İC Haznedaroğlu, N Sayınalp, O Özcebe, S Aksu, H Demiroğlu, ... Turkish Journal of Hematology 37 (2), 116, 2020 | 9 | 2020 |
Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper) R Ciftciler, AE Ciftciler, UY Malkan, IC Haznedaroglu SAGE Open Medicine 8, 2050312120907811, 2020 | 9 | 2020 |
A unique case of complex variant translocation of t (6; 9; 22)(p22; q34; q11. 2), der (19) in a newly diagnosed patient with chronic myeloid leukemia R Ciftciler, EA Saglam, A Inanc, O Ozcebe, IC Haznedaroglu Cancer Genetics 237, 78-81, 2019 | 9 | 2019 |
Comparison of myeloablative versus reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: a cohort study R Çiftçiler, H Göker, H Demiroğlu, E Aladağ, S Aksu, İC Haznedaroğlu, ... Turkish Journal of Hematology 36 (2), 88, 2019 | 9 | 2019 |
Efficacy and feasibility of allogeneic hematopoietic stem-cell transplantation in the treatment of refractory acute myeloid leukemia R Ciftciler, H Demiroglu, Y Buyukasık, E Aladag, S Aksu, IC Haznedaroglu, ... Clinical Lymphoma Myeloma and Leukemia 19 (3), 177-182, 2019 | 9 | 2019 |
Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance R Ciftciler, A Koluman, İC Haznedaroğlu, N Akar Turkish journal of medical sciences 49 (1), 347-355, 2019 | 9 | 2019 |
Evaluation of prognostic significance of the international staging system according to glomerular filtration rate in newly diagnosed multiple myeloma patients eligible for … R Ciftciler, H Göker, H Demiroğlu, İC Haznedaroğlu, N Sayınalp, S Aksu, ... Turkish Journal of Hematology 38 (1), 33, 2021 | 8 | 2021 |
COVID-19, renin-angiotensin system, and hematopoiesis R Çiftçiler, İ HAZNEDAROĞLU Turkish Journal of Hematology 37 (3), 2020 | 8 | 2020 |